In patients at high risk for RA, abatacept reduced inflammation and RA development at 6 mo.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 38950394.
- Also identified by DOI 10.7326/ANNALS-24-00740-JC.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Rech J, Tascilar K, Hagen M, et al. <b>Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial.</b> Lancet. 2024;403:850-859. 38364841.
Medical subject headings
- Abatacept
- Antirheumatic Agents
- Arthritis, Rheumatoid
- Inflammation